Biology Reference
In-Depth Information
Li Y, Arnold JMO, Pampillo M, Babwah AV, Peng TQ (2009) Taurine prevents cardiomyocyte
death by inhibiting NADPH oxidase-mediated calpain activation. Free Radic Biol Med
46:51-61
Lombardini JB (1996) Taurine depletion in the intact animal stimulates in vitro phosphorylation of
a 44-kDa protein present in the mitochondrial fraction of the rat heart. J Mol Cell Cardiol
28:1957-1961
Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prog-
nosis. Circulation 102:470-479
Moise NS, Pacioretty LM, Kallfelz FA, Stipanuk MH, King JM, Gilmour RF Jr (1991) Dietary
taurine deficiency and dilated cardiomyopathy in the fox. Am Heart J 121:541-547
Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH (2004) Taurine
supplementation reduces oxidative stress and improves cardiovascular function in an iron-over-
load murine model. Circulation 109:1877-1885
Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cat associated with
low plasma taurine:a reversible cardiomyopathy. Science 237:764-768
Sahin MA, Yucel O, Guler A, Doganci S, Jahollari A, Cingoz F, Arslan S, Gamsizkan M, Yaman
H, Demirkilic U (2011) Is there any cardioprotective role of Taurine during cold ischemic
period following global myocardial ischemia? J Cardiothorac Surg 6:31-38
Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS (2002) Role of oxidative
stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34:379-388
Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can
J Physiol Pharmacol 87:91-99
Shi YR, Bu DF, Qi YF, Gao L, Jiang HF, Pang YZ, Tang CS, Du JB (2002) Dysfunction of myo-
cardial taurine transport and effect of taurine supplement in rats with isoproterenol-induced
myocardial injury. Acta Pharmacol Sin 23(10):910-918
Shiny KS, Kumar SHS, Farvin KHS, Anandan R, Devadasan K (2005) Protective effect of taurine
on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. J Pharm
Pharmacol 57:1-5
Straznicka M, Gong G, Yan L, Scholz PM, Weiss HR (1999) Cyclic GMP protein kinase mediates
negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit
cardiac myocytes. J Cardiovasc Pharmacol 34:229-236
Tardiff JC (2006) Cardiac hypertrophy: stressing out the heart. J Clin Invest 116(6):1467-1470
Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ (1999) Activation of distinct cAMP-
dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res
84:1020-1031
Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compart-
mentation, structure and function of creatine kinase isoenzymes in tissues with high and
fluctuating energy demands: the “phosphocreatine circuit” for cellular energy homeostasis.
Biochem J 281:21-40
Xu YJ, Arneja AS, Tappia PS, Dhalla NS (2008) The potential health benefits of taurine in cardio-
vascular disease. Exp Clin Cardiol 13(2):57-65
Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y (2001) Distribution of twenty-
four hour urinary taurine excretion and association with ischemic heart disease mortality in 24
populations of 16 countries: results from the WHOCARDIAC study. Hypertens Res
24(4):453
Yang JC, Wu GF, Feng Y, Lu QF, Lin SM, Hu JM (2010) Effects of taurine on male reproduction
in rats of different ages. J Biomed Sci 17(Suppl 1):59-66
Search WWH ::
Custom Search